
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder in which the immune system attacks the myelin sheath , the protective covering around the peripheral nerves outside the brain and spinal cord. Unlike acute nerve disorders that develop and resolve over days or weeks, CIDP progresses or persists for at least eight weeks. This slow, ongoing course is one of the features clinicians use to distinguish CIDP from Guillain Barre syndrome (GBS), which typically reaches peak severity within four weeks.
Current US claims, based estimates suggest approximately 77,000 people in the United States live with CIDP, with an annual incidence of about 2.8 per 100,000 persons. The disorder affects men roughly twice as often as women and most commonly appears between the ages of 40 and 60, though it can occur at any age.
Because treatment can prevent further nerve damage, early recognition of CIDP symptoms matters. This guide reviews 12 common signs of CIDP, what they look like in everyday function, and the patterns that warrant medical evaluation , written for patients, caregivers, family members, and anyone trying to make sense of unexplained neurological symptoms.
CIDP symptoms usually develop gradually and often begin in the feet or hands before spreading to the legs and arms. Common symptoms include tingling, numbness, progressive weakness, balance problems, fatigue, and difficulty walking. Because these changes often appear slowly and affect both sides of the body, many people do not recognize them right away.
Below are 12 common CIDP symptoms, what they may feel like, and why they matter.
Tingling is one of the most common early signs of CIDP.
People often describe it as wearing invisible socks or gloves , the sensation feels detached from normal skin contact.
Demyelination interferes with normal sensory signals traveling between the body and the brain.
Occasional numbness has many causes. CIDP related numbness is different because it gradually becomes more noticeable over time.
Hands or feet may feel "thick" or "disconnected."
In typical CIDP, sensory nerves carrying proprioception and vibration sense are affected more than nerves carrying pain and temperature, so loss of position sense and balance often precedes obvious numbness.
Weakness in the legs is one of the hallmark symptoms of CIDP. Searches for progressive leg weakness often turn out to have a treatable underlying cause.
Legs feel heavy or unreliable. Many patients begin using handrails or stop activities they once managed without thinking.
CIDP characteristically affects both proximal muscles (around the hips and shoulders) and distal muscles (in the hands and feet), so weakness is felt in stairs, climbing and standing up , not just in the toes.
Although CIDP commonly starts in the legs, it typically progresses to affect the arms and hands as well.
Simple tasks that once felt automatic suddenly require more effort.
Weakness develops when the nerves supplying the muscles cannot transmit signals efficiently due to damaged myelin.
Balance problems are extremely common in CIDP and often appear before significant weakness develops.
Some describe feeling "off balance" without dizziness. Others say it feels like walking on a moving surface, even on solid ground.
Damage to large sensory fibers that carry position sense impairs the brain's awareness of where the limbs are in space. This is particularly noticeable in the dark or with eyes closed, when vision can no longer compensate.
People with CIDP often report that tripping became more frequent long before they received a diagnosis.
Many patients initially assume they are simply becoming clumsy. Falls feel sudden and unexplained , as if the floor "came up faster" than expected.
Weakness and impaired position sense both contribute to instability, a combination that distinguishes CIDP related falls from typical age related unsteadiness.
Foot drop occurs when the muscles that lift the front of the foot become too weak to clear the floor during walking.
Walking may require exaggerated, high, stepping movements to avoid catching the foot.
Demyelination of the motor nerves supplying the lower leg interferes with the muscle contraction needed to dorsiflex the foot.
Fatigue is one of the most consistently reported symptoms of CIDP.
The fatigue is often physical rather than mental, muscles "give up" before the mind feels tired.
Weakened muscles must work harder to perform ordinary tasks, and impaired nerve conduction adds to the energy cost of movement.
Pain is not part of every CIDP case, but a systematic review estimated that roughly 46% of people with CIDP experience pain at some point during their illness, more often proximal or radicular (in the back and limbs) than burning pain in the feet.
Pain often becomes more noticeable at night, when there are fewer distractions and the nerves are at rest.
Damaged sensory nerves can send abnormal signals interpreted by the brain as pain. In typical CIDP, pain usually appears later in the disease course, after large, fiber sensory and motor symptoms.
Absent or reduced tendon reflexes in all limbs is one of the four core clinical features in the 2021 European Academy of Neurology / Peripheral Nerve Society (EAN/PNS) diagnostic criteria for typical CIDP , alongside symmetric weakness, sensory involvement of at least two limbs, and symptom duration of at least eight weeks.
Most people do not recognize this themselves. It is usually identified during a neurological examination when the doctor taps the knee, ankle, or elbow with a reflex hammer.
Reduced reflexes help distinguish CIDP from conditions in which reflexes remain normal, and they play a central role in the diagnostic workup.
Slowed nerve conduction interferes with the rapid signal exchange that reflexes require.
CIDP typically produces symmetric symptoms both feet, both legs, both hands.
The symmetry can be subtle at first, one side may seem slightly worse, but on closer attention, both sides are affected to some degree.
This symmetric pattern helps clinicians distinguish typical CIDP from injuries or focal nerve disorders, which usually affect only one side. Asymmetric symptoms can occur in CIDP variants (such as multifocal or Lewis, Sumner syndrome) but are not characteristic of typical CIDP.
The most defining feature of CIDP is not any single symptom but the way symptoms progress.
CIDP symptoms continue to worsen or persist for at least eight weeks. This is the threshold that separates CIDP from GBS, in which symptoms reach peak severity within four weeks and then plateau.
The earliest signs typically appear in the feet and hands, then spread upward toward the legs and arms. Tingling or numbness usually starts in the toes or fingertips and gradually extends. People often report legs that feel unusually heavy when climbing stairs, reduced steadiness while walking (particularly in low light), and difficulty handling buttons, keys, or small objects.
Because these symptoms develop gradually, they are frequently mistaken for other conditions.
CIDP rarely appears overnight. Symptoms are commonly attributed to:
Diabetes is the most common comorbidity in people with CIDP, present in roughly half of patients in recent US data. Because the symptoms of diabetic peripheral neuropathy overlap heavily with CIDP, the autoimmune disorder is often missed or misdiagnosed in people with diabetes, delaying treatment that could slow nerve damage.
The gradual progression of symptoms is another reason diagnosis is often delayed, many people adapt to worsening symptoms without realizing how much their abilities have changed.
When evaluating possible CIDP, neurologists typically look for:
These four clinical features form the core of the 2021 EAN/PNS criteria for typical CIDP. The diagnosis is then supported by nerve conduction studies and, in some cases, lumbar puncture or nerve imaging.
Although CIDP usually develops gradually, certain features warrant immediate evaluation:
These signs do not automatically mean CIDP, but they deserve urgent medical assessment to rule out acute neurological conditions.
Yes. CIDP can follow a progressive course (steady worsening), a relapsing, remitting course (cycles of improvement and return), or a monophasic course (a single episode lasting one to three years). Most patients experience either progressive or relapsing, remitting disease.
Because the disease course varies considerably between individuals, symptom changes should be discussed with a neurologist familiar with the patient's history.
Medical evaluation is appropriate when any of the following are present:
A neurologist can determine whether further testing is needed and identify the underlying cause of symptoms. For people whose symptoms have lasted more than eight weeks, understanding how CIDP is diagnosed can help prepare for that conversation.
Is CIDP hereditary?
No, CIDP is not considered a hereditary disease and is not directly passed from parent to child. It is an acquired autoimmune condition rather than a genetic disorder. While researchers believe some people may inherit a general tendency toward autoimmune diseases, most people with CIDP have no family history of the condition.
What are the first signs of CIDP?
The first signs of CIDP are usually tingling, numbness, and gradually worsening weakness in the feet or legs. Many people first notice pins and needles sensations, heavier legs when climbing stairs, or increasing difficulty with everyday activities. Because symptoms develop slowly, they are often mistaken for aging, stress, or other nerve conditions.
Are CIDP symptoms worse at night?
Yes, many people with CIDP report that tingling, burning, or nerve pain feel worse at night. Symptoms may become more noticeable when the body is at rest and there are fewer daytime distractions. Nighttime discomfort can vary from person to person and is not experienced by everyone with CIDP.
Does CIDP affect sleep?
Yes. Tingling, burning sensations, nerve pain, and muscle discomfort can interfere with sleep in some people with CIDP. Poor sleep may then contribute to the fatigue that many patients experience during the day. If sleep disturbances become persistent, discussing them with your healthcare provider may help identify ways to improve symptom management.
Can CIDP cause balance problems?
Yes. Balance problems are common in CIDP and may appear before significant muscle weakness develops. The condition can affect the sensory nerves responsible for proprioception, which helps your brain understand where your body is positioned in space. When these signals are impaired, walking may become unsteady, especially in low light or on uneven surfaces.
CIDP symptoms often begin gradually and can be easy to overlook at first. Tingling, numbness, progressive weakness, balance problems, and reduced reflexes can slowly interfere with daily life before patients or their families realize something more serious may be occurring.
Because CIDP is treatable and earlier intervention can prevent further nerve damage, persistent or progressive symptoms, especially when they affect both sides of the body and last longer than eight weeks, warrant evaluation by a neurologist.
Was this article helpful?

CIDP and GBS are two rare conditions that affect the nerves outside the brain and spinal c...

Chronic inflammatory demyelinating polyneuropathy, often called CIDP, is a rare condition ...

For people living with myasthenia gravis, the day arrives in pieces. A patient can pour co...
Get updates on verified clinical trials, emerging treatments, and research breakthroughs directly in your inbox. No spam, just science that matters.